Portal Diabetes, Inc.
Stacy Chambliss serves as the Chief Executive Officer of Portal Diabetes, Inc. since August 2023. Prior to this role, Chambliss was the Chief Executive Officer of Valencia Technologies from September 2010 to July 2022, where significant achievements included leading the company to a private valuation exceeding one billion dollars, obtaining FDA approval for a groundbreaking class III medical device, and developing a high-performing leadership team. As Chief Operating Officer, Chambliss was instrumental in preparing the company for its first commercial sales and enhancing manufacturing operations. Earlier roles included Chief Administrative Officer and Chief of Clinical, where leadership facilitated successful clinical trials. Chambliss co-founded Valencia Technologies and possesses a Bachelor of Science and Bachelor of Arts in Business and Philosophy from the University of Southern California, as well as a Juris Doctor degree from Notre Dame Law School.
This person is not in any teams
This person is not in any offices
Portal Diabetes, Inc.
At Portal Diabetes (PKA PhysioLogic Devices), we are committed to transforming the treatment of insulin-requiring diabetes. Our technology automatically controls glucose through a state-of-the-art implantable insulin pump paired with a glucose sensor. Normal insulin and glucose physiology is restored because the insulin is delivered deep in the abdomen for uptake by the liver. Our new approach – fully automatic and implantable – gives people true freedom from the heavy burden of insulin therapy.